Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report

BACKGROUND: Gefitinib remains an excellent treatment option for patients with a variety of cancers, including non small cell lung cancer (NSCLC). However, clinicians must be aware of the potential of gefitinib to cause an inflammatory reaction in the skin, lungs and bladder. CASE PRESENTATION: We pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakawa, Maki, Nakamura, Kogenta, Yamada, Yoshiaki, Rosser, Charles J, Tobiume, Motoi, Saito, Hiroko, Hasegawa, Takaaki, Honda, Nobuaki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839984/
https://www.ncbi.nlm.nih.gov/pubmed/20187929
http://dx.doi.org/10.1186/1471-2490-10-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839984/
https://www.ncbi.nlm.nih.gov/pubmed/20187929
http://dx.doi.org/10.1186/1471-2490-10-6

Ejemplares similares